Preclinical evaluation of antimicrobial efficacy and biocompatibility of a novel bacterial barrier dressing

Wounds

Volumn 23, Issue 2, 2011, Pages 24-31

  Mikhaylova, Albina ^a   Liesenfeld, Bernd ^a   Moore, David ^a   Toreki, William ^a   Vella, Jillian ^a   Batich, Christopher ^b   Schultz, Gregory ^b  

^a Quick Med Technologies Inc   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952178458     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003;11(Suppl 1):S1-28.
2. Falanga V, Brem H, Ennis WJ, Wolcott R, Gould LJ, Ayello EA. Maintenance debridement in the treatment of difficult-toheal chronic wounds. Recommendations of an expert panel. Ostomy Wound Manage. 2008;(Suppl):2-13.
3. Müller G, Kramer A. Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. J Antimicrob Chemother. 2008;61(6):1281-1287. (Pubitemid 351753595)
4. Burd A, Kwok CH, Hung SC, et al. A comparative study of the cytotoxicity of silver-based dressings in monolayer cell, tissue explant, and animal models. Wound Repair Regen. 2007;15(1):94-104. (Pubitemid 46146668)
5. Poon VK, Burd A. In vitro cytotoxity of silver: implication for clinical wound care. Burns. 2004;30(2):140-147. (Pubitemid 38199863)
6. Silver S. Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiol Rev. 2003;27(2-3):341-353. (Pubitemid 36694661)
7. Fredriksson C, Kratz G, Huss F. Accumulation of silver and delayed re-epithelialization in normal human skin: an exvivo study of different silver dressings. WOUNDS. 2009;21(5):116-123.
8. Walker M, Cochrane CA, Bowler PG, Parsons D, Bradshaw P. Silver deposition and tissue staining associated with wound dressings containing silver. Ostomy Wound Manage. 2006;52(1):42-50.
9. Wang XQ, Chang HE, Francis R, et al. Silver deposits in cutaneous burn scar tissue is a common phenomenon following application of a silver dressing. J Cutan Pathol. 2009;36(7):788-792.
10. Trop M, Novak M, Rodl S, Hellbom B, Kroell W, Goessler W. Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J Trauma. 2006;60(3):648-652.
11. Thorn RM, Greenman J, Austin AJ. In-vitro method to assess the antimicrobial activity and potential efficacy of novel types of wound dressings. J Appl Microbiol. 2005;99(4):895-901. (Pubitemid 41399832)
12. Gilbert P, Moore LE. Cationic antiseptics: diversity of action under a common epithet. J Appl Microbiol. 2005;99(4):703-715. (Pubitemid 41399812)
13. Poole K. Mechanism of bacterial biocide and antibiotic resistance. J Appl Microbiol. 2002:92(Suppl):55S-64S. (Pubitemid 34535506)
14. Mikhaylova A, Liesenfeld B, Moore D. Bacterial resistance issues in wound care and wound dressings. Presented at: Symposium on Advanced Wound Care and Wound Healing Society Meeting; April 26-29, 2009; Dallas, TX.
15. American Association of Textile Chemists and Colorists (AATCC). Antibacterial finishes on textile materials: an assessment. Test method 100-1993. AATCC Technical Manual. 1998:143-144.
16. Davis SC, Bouzari N. Development of antimicrobials for wound care: in-vitro and in-vivo assessments. WOUNDS. 2004;16(11):344-347. (Pubitemid 39636156)
17. Holder IA, Durkee P, Supp AP, Boyce ST. Assessment of a silver-coated barrier dressing for potential use with skin grafts on excised burns. Burns. 2003;29(5):445-448. (Pubitemid 36918275)
18. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing (17th informational supplement). M100-S17. Wayne, PA; 2007.
19. International Organization for Standardization. Biological Evaluation of Medical Devices-ISO 10993, Part 5: Tests for In-vitro Cytotoxicity. Geneva, Switzerland; 1999.
20. Buehler EV. Occlusive patch method for skin sensitization in guinea pigs: the Buehler method. Food Chem Toxicol. 1994;32(2):97-101. (Pubitemid 24131126)
21. McGuckin M, Goldman R, Bolton L, Salcido R. The clinical relevance of microbiology in acute and chronic wounds. Adv Skin Wound Care. 2003;16(1):12-23.
22. Kirby JP, Mazuski JE. Prevention of surgical site infection. Surg Clin North Am. 2009;89(2):365-389.
23. Bhatia SK, Yetter AB. Correlation of visual in vitro cytotoxicity ratings of biomaterials with quantitative in vitro cell viability measurements. Cell Biol Toxicol. 2008;24(4):315-319. (Pubitemid 351875255)
24. Van Den Plas D, De Smet K, Lens D, Sollie P. Differential cell death programmes induced by silver dressings in vitro. Eur J Dermatol. 2008;18(4):416-421. (Pubitemid 352031852)
25. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999;12(1):147-179. (Pubitemid 29055958)
26. Gilbert P. Avoiding the resistance pitfall in infection control. Does the use of antiseptic products contribute to the spread of antibiotic resistance? Ostomy Wound Manage. 2006;52(10A Suppl):1S-3S.
27. Hidalgo E, Bartolomé R, Barroso C, Moreno A, Dominguez C. Silver nitrate: antimicrobial activity related to cytotoxicity in cultured human fibroblasts. Skin Pharmacol Appl Skin Physiol. 1998;11(3):140-151. (Pubitemid 28466445)
28. Paddle-Ledinek JE, Nasa Z, Cleland HJ. Effect of different wound dressings on cell viability and proliferation. Plast Reconstr Surg. 2006;117(7 Suppl):110S-118S. (Pubitemid 44317774)
29. Dunn K, Edwards-Jones V. The role of Acticoat with nanocrystalline silver in the management of burns. Burns. 2004;30(Suppl 1):S1-9. (Pubitemid 39140960)